Advances INM-901 program targeting several biological pathways associated with Alzheimer's diseaseFurther develops INM-089 demonstrating neuroprotection in the treatment of dry Age-related Macular ...
Thermo Fisher Scientific expands oral solid dose development and manufacturing capabilities across North America: Waltham, Massachusetts Monday, September 30, 2024, 17:00 Hrs [IST ...